Twist Bioscience shares surge 72% on AI-driven drug discovery momentum
TWST Twist Bioscience Corp
$122.59 -7.22%
View chart & analysis → - 1Twist Bioscience shares have risen 72% since the last report.
- 2Twist Bioscience is projected to have fourth-quarter revenue of $123.4 million.
- 3Twist Bioscience revenue is expected to grow by nearly 25% compared to the same period last year.
So what's the key point?
Twist Bioscience shares rose significantly by 72 percent. This is because revenue is expected to increase by about 25 percent compared to last year, as experts predicted.
Source Earnings Whispers · View original ↗
Nothing hidden: past picks and how they did against the S&P 500.